Expression of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Receptor DR5 in Ewing Sarcoma Family Tumors (ESFT)

被引:0
|
作者
Galli, S. [1 ]
Li, G. [1 ]
Ren, Y. [1 ]
Tsokos, M. [1 ]
机构
[1] NCI, NIH, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1569
引用
收藏
页码:346A / 346A
页数:1
相关论文
共 50 条
  • [1] Expression of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Receptor DR5 in Ewing Sarcoma Family Tumors (ESFT)
    Galli, S.
    Li, G.
    Ren, Y.
    Tsokos, M.
    MODERN PATHOLOGY, 2009, 22 : 346A - 346A
  • [2] Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5
    Mitsiades, N
    Poulaki, V
    Mitsiades, C
    Tsokos, M
    CANCER RESEARCH, 2001, 61 (06) : 2704 - 2712
  • [3] Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor
    van der Sloot, Almer M.
    Tur, Vicente
    Szegezdi, Eva
    Mullally, Margaret M.
    Cool, Robbert H.
    Samali, Afshin
    Serrano, Luis
    Quax, Wim J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (23) : 8634 - 8639
  • [4] Apoptotic responsiveness of the Ewing's sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)
    Van Valen, F
    Fulda, S
    Truckenbrod, B
    Eckervogt, V
    Sonnemann, J
    Hillmann, A
    Rödl, R
    Hoffmann, C
    Winkelmann, W
    Schäfer, L
    Dockhorn-Dworniczak, B
    Wessel, T
    Boos, J
    Debatin, KM
    Jürgens, H
    INTERNATIONAL JOURNAL OF CANCER, 2000, 88 (02) : 252 - 259
  • [5] Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Receptor Expression in Patients with Neuroendocrine Neoplasia
    Saettele, R.
    Jann, H.
    Fischer, C.
    Pape, U. F.
    Schefold, J. C.
    Koschny, R.
    Pschowski, R.
    NEUROENDOCRINOLOGY, 2018, 106 : 17 - 17
  • [6] Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor
    Wu, GS
    Burns, TF
    Zhan, Y
    Alnemri, ES
    El-Deiry, WS
    CANCER RESEARCH, 1999, 59 (12) : 2770 - 2775
  • [7] Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling
    Thorburn, Andrew
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (06) : 461 - 465
  • [8] Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) and Its Death Receptor (DR5) in Peyronie's Disease. A Biomolecular Study of Apoptosis Activation
    Loreto, Carla
    Barbagli, Guido
    Djinovic, Rados
    Vespasiani, Giuseppe
    Carnazza, Maria Luisa
    Miano, Roberto
    Musumeci, Giuseppe
    Sansalone, Salvatore
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 (01): : 109 - 115
  • [9] Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation
    Jung, Eun Mi
    Park, Jong-Wook
    Choi, Kyeong Sook
    Park, Jeen-Woo
    Lee, Hyung I. L.
    Lee, Kyung-Seop
    Kwon, Taeg Kyu
    CARCINOGENESIS, 2006, 27 (10) : 2008 - 2017
  • [10] The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis
    Michowitz, Y
    Goldstein, E
    Roth, A
    Afek, A
    Abashidze, A
    Ben Gal, Y
    Keren, G
    George, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (07) : 1018 - 1024